Stock Market & Financial Investment News

News Breaks March 18, 2013 06:55 EDT HLS HealthSouth downgraded to Neutral from Buy at UBS UBS downgraded HealthSouth due to valuation. Price target lowered to $27 from $29.50. News For HLS From The Last 14 Days Check below for free stories on HLS the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for HLS Sign up for a free trial to see the rest of the stories you've been missing.